How Poly Medicure Plans to Double Global Sales by FY30

Indian medical technology leader Poly Medicure is targeting a massive international expansion to double its global revenue by FY30. Currently, the company relies on overseas markets for nearly 68% of its total revenue. Consequently, the firm is strengthening its manufacturing footprint and introducing over 50 new clinical products to accelerate global sales.

Strategic Expansion of Poly Medicure Manufacturing

Today, the company is building two state-of-the-art manufacturing plants to support this next phase of growth. In addition, the brand is targeting high-margin fields including cardiology, oncology, and critical care. While European markets look beyond China for supply chain diversification, India has a unique opportunity to capture high-tech device manufacturing. Furthermore, local manufacturing will significantly lower the cost of single-use dialysers for renal care in India. This shift will make critical treatments much more affordable for domestic patients.

Focusing on High-Tech Devices and Emerging Markets

Initially, early waves of global manufacturing relocation favored Southeast Asian nations like Vietnam and Malaysia. However, these countries primarily secure low-tech assembly contracts. Today, India is positioning itself to secure complex, high-tech medical device manufacturing. Specifically, emerging markets in the Global South represent the largest export potential for Indian manufacturers. These regions include the Middle East, Southeast Asia, Africa, and Latin America. At the same time, the company expects its domestic business in India to grow by 20% to 25% annually. Therefore, domestic growth will outpace international sales over the next few years.

Frequently Asked Questions

Q1: What is the main international goal for Poly Medicure by FY30?

The company aims to double its international business revenue by FY30. To achieve this, it plans to utilize two upcoming manufacturing facilities and introduce over 50 new clinical products.

Q2: Why is local manufacturing important for renal care in India?

Currently, renal care products are highly import-dependent and expensive. Therefore, local production will lower treatment costs and encourage the clinical transition toward single-use dialysers.

References

1. Poly Medicure bets on new facilities, products to double international business:MD – ETHealthworld
2. Poly Medicure Investing In Facilities And Products To Double International Sales – Sahi
3. Poly Medicure Targets Doubling Export Sales by FY30 – Whalesbook

Disclaimer: This article was automatically generated from publicly available sources and is provided for informational and educational purposes only. OC Academy does not exercise editorial control or claim authorship over this content. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider and refer to current local and national clinical guidelines.